Fate Therapeutics, Inc. (FRA:F6T)
Germany
· Delayed Price · Currency is EUR 0.947
+0.050 (5.62%)
At close: Dec 5, 2025
Fate Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -156.09 | -186.26 | -160.93 | -281.72 | -212.15 | -173.39 | Upgrade
|
| Depreciation & Amortization | 14.65 | 18.96 | 18.28 | 13.76 | 5.85 | 3.09 | Upgrade
|
| Other Amortization | - | - | 7.2 | 2.68 | 4 | 3.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | 0.94 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 14.74 | 14.74 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.26 | -9.08 | -11.4 | -0.26 | 5.07 | 1.68 | Upgrade
|
| Stock-Based Compensation | 28.52 | 41.5 | 43.46 | 78.73 | 54.36 | 30.75 | Upgrade
|
| Other Operating Activities | -1.38 | -1.71 | -48.06 | -26.69 | -22.09 | 108.31 | Upgrade
|
| Change in Accounts Receivable | 3.45 | -1.11 | 36.65 | -29.8 | -3.16 | -5.52 | Upgrade
|
| Change in Accounts Payable | -9.24 | -1.66 | -28.94 | 14.25 | 5.91 | -1.55 | Upgrade
|
| Change in Other Net Operating Assets | -0.91 | 0.82 | 11.47 | -19.16 | -0.65 | -5.7 | Upgrade
|
| Operating Cash Flow | -110.57 | -122.87 | -132.26 | -248.21 | -162.87 | -39.23 | Upgrade
|
| Capital Expenditures | -4.86 | -0.73 | -6.15 | -35.57 | -50.7 | -4.93 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.13 | - | - | - | - | - | Upgrade
|
| Investment in Securities | 111.09 | 12.95 | 118.82 | 202.32 | -273.32 | -156.14 | Upgrade
|
| Investing Cash Flow | 106.35 | 12.22 | 112.67 | 166.75 | -324.02 | -161.08 | Upgrade
|
| Issuance of Common Stock | - | 74.83 | 0.09 | 9.21 | 432.45 | 282.35 | Upgrade
|
| Other Financing Activities | 6.93 | 25.07 | - | - | 20.68 | 0.49 | Upgrade
|
| Financing Cash Flow | 6.93 | 99.89 | 0.09 | 9.21 | 453.13 | 282.84 | Upgrade
|
| Net Cash Flow | 2.71 | -10.76 | -19.51 | -72.25 | -33.76 | 82.53 | Upgrade
|
| Free Cash Flow | -115.43 | -123.6 | -138.42 | -283.77 | -213.57 | -44.16 | Upgrade
|
| Free Cash Flow Margin | -1617.32% | -906.79% | -217.87% | -294.68% | -382.43% | -140.49% | Upgrade
|
| Free Cash Flow Per Share | -0.97 | -1.09 | -1.41 | -2.93 | -2.25 | -0.54 | Upgrade
|
| Levered Free Cash Flow | -61.31 | -60.77 | -82.31 | -148.77 | -134.71 | 2.31 | Upgrade
|
| Unlevered Free Cash Flow | -61.31 | -60.77 | -82.31 | -148.77 | -134.71 | 2.31 | Upgrade
|
| Change in Working Capital | -6.71 | -1.96 | 19.18 | -34.71 | 2.1 | -12.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.